title: Chemoimmunotherapy with fludarabine, cytoxan and rituximab regimen: to use, not to use, or give it as "FCR-LITE"?
authors.affiliation: Hematology Unit, Bnai-Zion Medical Center , Haifa , Israel.
authors.forename: Tamar
authors.initials: T
authors.lastname: Tadmor
authors.forename: Peter
authors.initials: P
authors.lastname: McLaughlin
authors.forename: Aaron
authors.initials: A
authors.lastname: Polliack
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male